Next Article in Journal
Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
Next Article in Special Issue
High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer
Previous Article in Journal
Enhanced Nitrite-Mediated Relaxation of Placental Blood Vessels Exposed to Hypoxia Is Preserved in Pregnancies Complicated by Fetal Growth Restriction
Review

Biomarkers for Cancer Cachexia: A Mini Review

1
Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia
2
Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3
Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Kwang Seok Ahn
Int. J. Mol. Sci. 2021, 22(9), 4501; https://doi.org/10.3390/ijms22094501
Received: 25 March 2021 / Revised: 14 April 2021 / Accepted: 23 April 2021 / Published: 26 April 2021
(This article belongs to the Special Issue Biomarkers of Colorectal Cancer)
Cancer cachexia is a common condition in many cancer patients, particularly those with advanced disease. Cancer cachexia patients are generally less tolerant to chemotherapies and radiotherapies, largely limiting their treatment options. While the search for treatments of this condition are ongoing, standards for the efficacy of treatments have yet to be developed. Current diagnostic criteria for cancer cachexia are primarily based on loss of body mass and muscle function. However, these criteria are rather limiting, and in time, when weight loss is noticeable, it may be too late for treatment. Consequently, biomarkers for cancer cachexia would be valuable adjuncts to current diagnostic criteria, and for assessing potential treatments. Using high throughput methods such as “omics approaches”, a plethora of potential biomarkers have been identified. This article reviews and summarizes current studies of biomarkers for cancer cachexia. View Full-Text
Keywords: cancer cachexia; biomarkers; cachexia-inducing factors cancer cachexia; biomarkers; cachexia-inducing factors
Show Figures

Graphical abstract

MDPI and ACS Style

Cao, Z.; Zhao, K.; Jose, I.; Hoogenraad, N.J.; Osellame, L.D. Biomarkers for Cancer Cachexia: A Mini Review. Int. J. Mol. Sci. 2021, 22, 4501. https://doi.org/10.3390/ijms22094501

AMA Style

Cao Z, Zhao K, Jose I, Hoogenraad NJ, Osellame LD. Biomarkers for Cancer Cachexia: A Mini Review. International Journal of Molecular Sciences. 2021; 22(9):4501. https://doi.org/10.3390/ijms22094501

Chicago/Turabian Style

Cao, Zhipeng, Kening Zhao, Irvin Jose, Nick J. Hoogenraad, and Laura D. Osellame 2021. "Biomarkers for Cancer Cachexia: A Mini Review" International Journal of Molecular Sciences 22, no. 9: 4501. https://doi.org/10.3390/ijms22094501

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop